Public Profile

MaxCyte

MaxCyte, Inc., a leading player in the cell engineering industry, is headquartered in the United States, with significant operations across Europe and Asia. Founded in 1998, the company has established itself as a pioneer in the development of cell-based therapies and drug discovery solutions. MaxCyte's core offerings include its proprietary Flow Electroporation® technology, which enables the efficient delivery of nucleic acids into various cell types. This unique approach not only enhances the development of cell therapies but also accelerates the discovery of new drugs. With a strong market position, MaxCyte has achieved notable milestones, including partnerships with major pharmaceutical companies and biotechs, solidifying its reputation as a trusted provider in the biopharmaceutical sector.

DitchCarbon Score

How does MaxCyte's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

MaxCyte's score of 13 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

67%

MaxCyte's reported carbon emissions

MaxCyte, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed emissions data, it is essential for MaxCyte to establish clear climate commitments and reduction initiatives to align with industry standards and expectations for sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. MaxCyte's primary industry is Fabricated metal products, except machinery and equipment (28), which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. MaxCyte is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

MaxCyte is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Precigen, Inc.

US
Health and social work services (85)
Updated 14 days ago

Applied DNA Sciences

US
Leather and leather products (19)
Updated 21 days ago

OriGene Technologies, Inc.

US
Chemicals nec
Updated 3 days ago

Cobra Biologics Limited

GB
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Juno Therapeutics, Inc.

US
Health and social work services (85)
Updated 21 days ago

Aldevron, LLC

US
Research and development services (73)
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers